glp-1 drugs kidney disease TrimRX Real-World Evidence for GLP-1 Receptor
Description
10.1016/s0140-6736(23)01185-6
The dipeptidyl peptidase-4 inhibitor linagliptin attenuates inflammation and accelerates epithelialization in wounds of diabetic ob/ob mice
Tseng, J
The FDA approved tirzepatide under the brand name Mounjaro in May 2022 for improving glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise
